In a similar study reported this January, patients' own cells were found to have become incorporated in transplanted hearts.
Diabetic mice that were treated with the cells were found to have normal blood sugar levels for several weeks.
In each case, the cells were found to produce less nitric oxide, a chemical important for maintaining the health of the cardiovascular system.
In the study, published in Science, the engineered HEK cells were found to outperform normal pancreatic cells in terms of their ability to regulate blood sugar in mice.
Microscopically, spindle-shaped tumor cells were found to form fascicles and storiform pattern.
In addition, these T cells were found to produce more cytokines than control RBcs-untreated DCs.
L-929 cells were found to grow logarithmically on SIBS coatings and on SIBS incorporating SWNTs.
Colon cancer and chronic myelogenous leukemia cells were found to be most susceptible to kefir extracts.
LOX cells were found to be quite resistant to ALA- and M-ALA-induced phototoxicity.
Effector responses generated by NKT cells were found to be MHC II-independent and CD1d-restricted.
Cells were found to be released from the microbeads after 7 days.
